Abstract
BackgroundPreconception carrier screening (PCS) provides the potential to empower couples to make reproductive choices before having an affected child. An important question is what factors influence the decision to use or not use PCS.MethodsWe analysed the relationship between knowledge, attitudes and intentions to participate in PCS using logistic regression in 832 participants in Western Australia.ResultsTwo-thirds of participants said they would take the test, with 92% of these supporting screening for diseases reducing the lifespan of children and infants. Those who had good genetic knowledge were seven times more likely to intend to use PCS (p≤0.001), while those with high genetic knowledge were four times more likely to (p=0.002) and raised concerns such as insurance and confidentiality.Decreasing genetic knowledge correlated positively with religiosity and apprehension (p≤0.001), which correlated negatively with intention to use PCS (p≤0.001). Increasing genetic knowledge correlated positively with factors representing positive attitudes (p≤0.001), which correlated positively with intention to use PCS (p≤0.001). Many participants with good genetic knowledge nevertheless answered questions that tested understanding incorrectly.80% of participants stated they would prefer to access the test through their general practitioners and 30% would pay up to $A200.ConclusionsKnowledge is instrumental in influencing participation. Having good genetic knowledge may not be enough to understand core concepts of PCS and may impact informed decision-making. This study recommends that continuous education of health professionals and thus the community, in PCS is crucial to reduce misconceptions.
Subject
Genetics (clinical),Genetics
Reference46 articles.
1. Archibald AD , Smith MJ , Burgess T , Scarff KL , Elliott J , Hunt CE , Barns-Jenkins C , Holt C , Sandoval K , Kumar S V , Ward L , Allen EC , Collis SV , Cowie S , Francis D , Delatycki MB , Yiu EM , Massie RJ , Pertile MD , du Sart D , Bruno D , Amor DJ . Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests. 2017.
2. Population-based preconception carrier screening: how potential users from the general population view a test for 50 serious diseases;Plantinga;Eur J Hum Genet,2016
3. WHO. Births with Down’s syndrome per 100 000 live births. Secondary Births with Down’s syndrome per 100 000 live births. 2017. https://gateway.euro.who.int/en/indicators/hfa_603-7120-births-with-downs-syndrome-per-100-000-live-births/
4. Next-generation community genetics for low- and middle-income countries
5. Walker CE , Mahede T , Davis G , Miller LJ , Girschik J , Brameld K , Sun W , Rath A , Aymé S , Zubrick SR , Baynam GS , Molster C , Dawkins HJS , Weeramanthri TS . The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort. Genet Med 2017;19.doi:10.1038/gim.2016.143
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献